Are you Dr. Oran?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Betul Oran, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- Hacettepe University FOMClass of 1995
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2011 - 2026
- OK State Medical License 2020 - 2021
- MA State Medical License 2004 - 2013
- MN State Medical License 2008 - 2012
- American Board of Internal Medicine Hematology
Clinical Trials
- Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) Start of enrollment: 2013 Dec 16
- Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation Start of enrollment: 2015 Mar 03
- Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection Start of enrollment: 2015 Feb 19
- Join now to see all
Publications & Presentations
PubMed
- Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.Jayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, Guillin Tang, Tapan Kadia
Haematologica. 2024-12-12 - Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy amo...Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick Reville, Nicholas J Short
Cancer. 2024-10-01 - 2 citationsDonor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
Press Mentions
- Life After My Leukemia Diagnosis and Stem Cell TransplantJune 6th, 2018